137 related articles for article (PubMed ID: 29729199)
1. Vacuolar Protein Sorting 33B Is a Tumor Suppressor in Hepatocarcinogenesis.
Wang C; Cheng Y; Zhang X; Li N; Zhang L; Wang S; Tong X; Xu Y; Chen GQ; Cheng S; Fan X; Liu J
Hepatology; 2018 Dec; 68(6):2239-2253. PubMed ID: 29729199
[TBL] [Abstract][Full Text] [Related]
2. Vps33b is crucial for structural and functional hepatocyte polarity.
Hanley J; Dhar DK; Mazzacuva F; Fiadeiro R; Burden JJ; Lyne AM; Smith H; Straatman-Iwanowska A; Banushi B; Virasami A; Mills K; Lemaigre FP; Knisely AS; Howe S; Sebire N; Waddington SN; Paulusma CC; Clayton P; Gissen P
J Hepatol; 2017 May; 66(5):1001-1011. PubMed ID: 28082148
[TBL] [Abstract][Full Text] [Related]
3. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress.
Lu M; Wu J; Hao ZW; Shang YK; Xu J; Nan G; Li X; Chen ZN; Bian H
Hepatology; 2018 Jul; 68(1):317-332. PubMed ID: 29356040
[TBL] [Abstract][Full Text] [Related]
4. Vps33b regulates Vwf-positive vesicular trafficking in megakaryocytes.
Dai J; Lu Y; Wang C; Chen X; Fan X; Gu H; Wu X; Wang K; Gartner TK; Zheng J; Chen G; Wang X; Liu J
J Pathol; 2016 Sep; 240(1):108-19. PubMed ID: 27319744
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
7. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
Potikha T; Pappo O; Mizrahi L; Olam D; Maller SM; Rabinovich GA; Galun E; Goldenberg DS
FASEB J; 2019 Jul; 33(7):7995-8007. PubMed ID: 30897344
[TBL] [Abstract][Full Text] [Related]
8. FUN14 Domain-Containing 1-Mediated Mitophagy Suppresses Hepatocarcinogenesis by Inhibition of Inflammasome Activation in Mice.
Li W; Li Y; Siraj S; Jin H; Fan Y; Yang X; Huang X; Wang X; Wang J; Liu L; Du L; Chen Q
Hepatology; 2019 Feb; 69(2):604-621. PubMed ID: 30053328
[TBL] [Abstract][Full Text] [Related]
9. VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.
Chen Y; Liu Z; Wang H; Tang Z; Liu Y; Liang Z; Deng X; Zhao M; Fu Q; Li L; Cai H; Xie W; Fang W
Int J Cancer; 2020 Jan; 146(2):496-509. PubMed ID: 31125123
[TBL] [Abstract][Full Text] [Related]
10. Sorting protein VPS33B regulates exosomal autocrine signaling to mediate hematopoiesis and leukemogenesis.
Gu H; Chen C; Hao X; Wang C; Zhang X; Li Z; Shao H; Zeng H; Yu Z; Xie L; Xia F; Zhang F; Liu X; Zhang Y; Jiang H; Zhu J; Wan J; Wang C; Weng W; Xie J; Tao M; Zhang CC; Liu J; Chen GQ; Zheng J
J Clin Invest; 2016 Dec; 126(12):4537-4553. PubMed ID: 27797340
[TBL] [Abstract][Full Text] [Related]
11. Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis.
Waidmann O; Pleli T; Weigert A; Imelmann E; Kakoschky B; Schmithals C; Döring C; Frank M; Longerich T; Köberle V; Hansmann ML; Brüne B; Zeuzem S; Piiper A; Dikic I
Sci Rep; 2020 Oct; 10(1):16264. PubMed ID: 33004985
[TBL] [Abstract][Full Text] [Related]
12. Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.
Sunami Y; Ringelhan M; Kokai E; Lu M; O'Connor T; Lorentzen A; Weber A; Rodewald AK; Müllhaupt B; Terracciano L; Gul S; Wissel S; Leithäuser F; Krappmann D; Riedl P; Hartmann D; Schirmbeck R; Strnad P; Hüser N; Kleeff J; Friess H; Schmid RM; Geisler F; Wirth T; Heikenwalder M
Hepatology; 2016 May; 63(5):1592-607. PubMed ID: 26892811
[TBL] [Abstract][Full Text] [Related]
13. Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.
Sagawa H; Naiki-Ito A; Kato H; Naiki T; Yamashita Y; Suzuki S; Sato S; Shiomi K; Kato A; Kuno T; Matsuo Y; Kimura M; Takeyama H; Takahashi S
Carcinogenesis; 2015 Dec; 36(12):1539-49. PubMed ID: 26494227
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of platelet α-granule biogenesis: study of cargo transport and the VPS33B-VPS16B complex in a model system.
Ambrosio AL; Di Pietro SM
Blood Adv; 2019 Sep; 3(17):2617-2626. PubMed ID: 31501156
[TBL] [Abstract][Full Text] [Related]
15. Rare Inherited Cholestatic Disorders and Molecular Links to Hepatocarcinogenesis.
Jeyaraj R; Kelly D
Cells; 2022 Aug; 11(16):. PubMed ID: 36010647
[TBL] [Abstract][Full Text] [Related]
16. Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background.
Chung SI; Moon H; Kim DY; Cho KJ; Ju HL; Kim DY; Ahn SH; Han KH; Ro SW
BMC Gastroenterol; 2016 Jan; 16():13. PubMed ID: 26821924
[TBL] [Abstract][Full Text] [Related]
17. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis.
Su B; Luo T; Zhu J; Fu J; Zhao X; Chen L; Zhang H; Ren Y; Yu L; Yang X; Wu M; Feng G; Li S; Chen Y; Wang H
Hepatology; 2015 Feb; 61(2):585-97. PubMed ID: 25294684
[TBL] [Abstract][Full Text] [Related]
19. Vps33b pathogenic mutations preferentially affect VIPAS39/SPE-39-positive endosomes.
Tornieri K; Zlatic SA; Mullin AP; Werner E; Harrison R; L'hernault SW; Faundez V
Hum Mol Genet; 2013 Dec; 22(25):5215-28. PubMed ID: 23918659
[TBL] [Abstract][Full Text] [Related]
20. IGF-II induced by hepatitis B virus X protein regulates EMT via SUMO mediated loss of E-cadherin in mice.
Ha HL; Kwon T; Bak IS; Erikson RL; Kim BY; Yu DY
Oncotarget; 2016 Aug; 7(35):56944-56957. PubMed ID: 27486970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
